Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Votion 2013 Abstract MiP2013"

From Bioblast
ย 
(11 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{Abstract
{{Abstract
|title=Votion DM, Mouithys-Mickalad A, Ceusters J, Lemieux H, Tosi I, Franck T, Art T, Niesten A, Serteyn D (2013) The challenge of understanding myopathies in horses using permeabilized muscle cells. Mitochondr Physiol Network 18.08.
|title=Votion DM, Mouithys-Mickalad A, Ceusters Justine D, Lemieux H, Tosi I, Franck T, Art T, Niesten A, Serteyn D (2013) The challenge of understanding myopathies in horses using permeabilized muscle cells. Mitochondr Physiol Network 18.08.
|authors=Votion DM, Mouithys-Mickalad A, Ceusters J, Lemieux H, Tosi I, Franck T, Art T, Niesten A, Serteyn D
|info=[[File:20091010 Dominique VOTION Reduite.jpg|right|120px|Marie-Dominique Votion]] [[MiP2013]], [[Laner 2013 Mitochondr Physiol Network MiP2013|Book of Abstracts Open Access]]
|authors=Votion DM, Mouithys-Mickalad A, Ceusters Justine D, Lemieux H, Tosi I, Franck T, Art T, Niesten A, Serteyn D
|year=2013
|year=2013
|event=MiP2013
|event=MiPNet18.08_MiP2013
|abstract=[[File:20091010 Dominique VOTION Reduite.jpg|right|120px|Marie-Dominique Votion]]
|abstract=In horses, myopathic syndromes are common but most often their aetiology and pathogenesis are unknown. Recently, the cause of Type 1 polysaccharide storage myopathy (PSSM) and the one of atypical myopathy (AM) have been discovered. Type 1 PSSM is caused by a glycogen synthase (GYS1) mutation [1] and is characterized by exercise-induced muscle damage. The frequently fatal syndrome of AM results from the ingestion of the toxin hypoglycin A contained in seeds of some Acer species [2]. The metabolite of hypoglycin A inhibits several acyl-CoA dehydrogenases leading to a multiple acyl-CoA dehydrogenases deficiency (MADD) phenotype. The mitochondrial respiration has never been determined in myopathic horses despite the potential role of mitochondria in the pathogenesis of inherited and acquired equine myopathies.
In horses, myopathic syndromes are common but most often their aetiology and pathogenesis are unknown. Recently, the cause of Type 1 polysaccharide storage myopathy (PSSM) and the one of atypical myopathy (AM) have been discovered. Type 1 PSSM is caused by a glycogen synthase (GYS1) mutation [1] and is characterized by exercise-induced muscle damage. The frequently fatal syndrome of AM results from the ingestion of the toxin hypoglycin A contained in seeds of some Acer species [2]. The metabolite of hypoglycin A inhibits several acyl-CoA dehydrogenases leading to a multiple acyl-CoA dehydrogenases deficiency (MADD) phenotype. The mitochondrial respiration has never been determined in myopathic horses despite the potential role of mitochondria in the pathogenesis of inherited and acquired equine myopathies.


High-resolution respirometry (HRR) and multiple substrate-uncoupler-inhibitor titration (SUIT) protocols were applied to study mitochondrial respiration in triceps brachii of horses suffering from PSSM (''N'' = 5), exertional rhabdomyolysis (ER) from unknown origin (''N'' = 3), and from AM (''N'' = 15). Respirometric parameters of myopathic horses were compared to those of healthy controls with specific fitness level according to the one of the group investigated [3].
High-resolution respirometry (HRR) and multiple substrate-uncoupler-inhibitor titration (SUIT) protocols were applied to study mitochondrial respiration in triceps brachii of horses suffering from PSSM (''N'' = 5), exertional rhabdomyolysis (ER) from unknown origin (''N'' = 3), and from AM (''N'' = 15). Respirometric parameters of myopathic horses were compared to those of healthy controls with specific fitness level according to the one of the group investigated [3].


With the exception of one PSSM horse (i.e. Horse PSSM+ in Fig. 1), all myopathic horses showed a severe decrease in muscle respiratory capacity. Flux control ratios, ''FCR'', and substrate control ratios, ''SCR'', indicate an increase of CI-linked respiratory capacity as a common feature to PSSM and ER horses whereas AM was characterized by a greater contribution of CII respiration on maximal OXPHOS capacity. This study shows that the understanding equine myopathies with HRR necessitates substrates supply to selected segments of the ETS and determination of maximal OXPHOS and ETS capacities.
With the exception of one PSSM horse (i.e. Horse PSSM+ in Fig. 1), all myopathic horses showed a severe decrease in muscle respiratory capacity. Flux control ratios, ''FCR'', and substrate control ratios, ''SCR'', indicate an increase of CI-linked respiratory capacity as a common feature to PSSM and ER horses whereas AM was characterized by a greater contribution of CII respiration on maximal OXPHOS capacity. This study shows that the understanding equine myopathies with HRR necessitates substrates supply to selected segments of the ET-pathway and determination of maximal OXPHOS and ET capacities.
|mipnetlab=BE Liege Votion DM, CA Edmonton Lemieux H
|mipnetlab=BE Liege Votion DM, CA Edmonton Lemieux H
}}
}}
{{Labeling
{{Labeling
|area=Respiration, mt-Biogenesis;mt-density, Exercise physiology;nutrition;life style, Pharmacology;toxicology
|area=Respiration, mt-Biogenesis;mt-density, Exercise physiology;nutrition;life style, Pharmacology;toxicology
|diseases=Myopathy
|organism=Horse
|organism=Horse
|tissues=Skeletal muscle
|tissues=Skeletal muscle
|preparations=Permeabilized tissue
|preparations=Permeabilized tissue
|diseases=Muscular dystrophy
|couplingstates=OXPHOS, ET
|couplingstates=OXPHOS, ETS
|pathways=F, N, S, NS, ROX
|substratestates=CI, CII, ETF, CI+II, ROX
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=MiP2013, Veterinary
|additional=MiP2013, Veterinary
}}
}}
__TOC__
== Affiliations and author contributions ==
== Affiliations and author contributions ==
1 - Equine Clinic, Faculty of Veterinary Medicine, University of Liege, Belgium; ย 
1 - Equine Clinic, Faculty of Veterinary Medicine, University of Liege, Belgium; 2 - Center for Oxygen Research and Development (CORD), Institute of Chemistry, University of Liege, Belgium; 3 - Campus Saint-Jean, University of Alberta, Edmonton, Canada. - Email: [email protected]
ย 
2 - Center for Oxygen Research and Development (CORD), Institute of Chemistry, University of Liege, Belgium; ย 
ย 
3 - Campus Saint-Jean, University of Alberta, Edmonton, Canada. ย 
ย 




== Figure 1 ==
== Figure 1 ==


Fig. 1: OXPHOS (''P'') and ETS (''E'') capacity (Oxygen flux [pmol O2.s-1.mg-1 wet weight) with CI- (GM<sub>''P''</sub>: glutamate+malate), CI+II-ย  (GMS<sub>''P''</sub> and GMS<sub>''E''</sub>: glutamate+malate+succinate), and CII-substrate (S(Rot)<sub>''E''</sub>: succinate+rotenone); ''N'': number of horses (2 or 3 runs per horse); ''n'' = number of runs for this horse. See text for other abbreviations.
Fig. 1: OXPHOS (''P'') and ET-pathway (''E'') capacity (Oxygen flux [pmol O2.s-1.mg-1 wet weight) with CI- (GM<sub>''P''</sub>: glutamate+malate), CI+II-ย  (GMS<sub>''P''</sub> and GMS<sub>''E''</sub>: glutamate+malate+succinate), and CII-substrate (S(Rot)<sub>''E''</sub>: succinate+rotenone); ''N'': number of horses (2 or 3 runs per horse); ''n'' = number of runs for this horse. See text for other abbreviations.




Line 45: Line 36:
# Votion DM, Van Galen G, Sweetman L, Boemer F, de Tullio P, Dopagne C, Lefรจre L, Mouihys-Mickalad A, Patarin F, Rouxhet S, Van Loon G, Serteyn D, Sponseller BT, Valberg SJ (2013) The toxic metabolite causing equine atypical myopathy in europe has been identified. Submitted.
# Votion DM, Van Galen G, Sweetman L, Boemer F, de Tullio P, Dopagne C, Lefรจre L, Mouihys-Mickalad A, Patarin F, Rouxhet S, Van Loon G, Serteyn D, Sponseller BT, Valberg SJ (2013) The toxic metabolite causing equine atypical myopathy in europe has been identified. Submitted.
# [[Votion 2012 PLoS One|Votion DM, Gnaiger E, Lemieux H, Mouithys-Mickalad A, Serteyn D (2012) Physical fitness and mitochondrial respiratory capacity in horse skeletal muscle. PLoS One 7: e34890.]]
# [[Votion 2012 PLoS One|Votion DM, Gnaiger E, Lemieux H, Mouithys-Mickalad A, Serteyn D (2012) Physical fitness and mitochondrial respiratory capacity in horse skeletal muscle. PLoS One 7: e34890.]]
__TOC__

Latest revision as of 15:29, 13 November 2017

Votion DM, Mouithys-Mickalad A, Ceusters Justine D, Lemieux H, Tosi I, Franck T, Art T, Niesten A, Serteyn D (2013) The challenge of understanding myopathies in horses using permeabilized muscle cells. Mitochondr Physiol Network 18.08.

Link:

Marie-Dominique Votion

MiP2013, Book of Abstracts Open Access

Votion DM, Mouithys-Mickalad A, Ceusters Justine D, Lemieux H, Tosi I, Franck T, Art T, Niesten A, Serteyn D (2013)

Event: MiPNet18.08_MiP2013

In horses, myopathic syndromes are common but most often their aetiology and pathogenesis are unknown. Recently, the cause of Type 1 polysaccharide storage myopathy (PSSM) and the one of atypical myopathy (AM) have been discovered. Type 1 PSSM is caused by a glycogen synthase (GYS1) mutation [1] and is characterized by exercise-induced muscle damage. The frequently fatal syndrome of AM results from the ingestion of the toxin hypoglycin A contained in seeds of some Acer species [2]. The metabolite of hypoglycin A inhibits several acyl-CoA dehydrogenases leading to a multiple acyl-CoA dehydrogenases deficiency (MADD) phenotype. The mitochondrial respiration has never been determined in myopathic horses despite the potential role of mitochondria in the pathogenesis of inherited and acquired equine myopathies.

High-resolution respirometry (HRR) and multiple substrate-uncoupler-inhibitor titration (SUIT) protocols were applied to study mitochondrial respiration in triceps brachii of horses suffering from PSSM (N = 5), exertional rhabdomyolysis (ER) from unknown origin (N = 3), and from AM (N = 15). Respirometric parameters of myopathic horses were compared to those of healthy controls with specific fitness level according to the one of the group investigated [3].

With the exception of one PSSM horse (i.e. Horse PSSM+ in Fig. 1), all myopathic horses showed a severe decrease in muscle respiratory capacity. Flux control ratios, FCR, and substrate control ratios, SCR, indicate an increase of CI-linked respiratory capacity as a common feature to PSSM and ER horses whereas AM was characterized by a greater contribution of CII respiration on maximal OXPHOS capacity. This study shows that the understanding equine myopathies with HRR necessitates substrates supply to selected segments of the ET-pathway and determination of maximal OXPHOS and ET capacities.


โ€ข O2k-Network Lab: BE Liege Votion DM, CA Edmonton Lemieux H


Labels: MiParea: Respiration, mt-Biogenesis;mt-density, Exercise physiology;nutrition;life style, Pharmacology;toxicology  Pathology: Myopathy 

Organism: Horse  Tissue;cell: Skeletal muscle  Preparation: Permeabilized tissue 


Coupling state: OXPHOS, ET  Pathway: F, N, S, NS, ROX  HRR: Oxygraph-2k 

MiP2013, Veterinary 

Affiliations and author contributions

1 - Equine Clinic, Faculty of Veterinary Medicine, University of Liege, Belgium; 2 - Center for Oxygen Research and Development (CORD), Institute of Chemistry, University of Liege, Belgium; 3 - Campus Saint-Jean, University of Alberta, Edmonton, Canada. - Email: [email protected]


Figure 1

Fig. 1: OXPHOS (P) and ET-pathway (E) capacity (Oxygen flux [pmol O2.s-1.mg-1 wet weight) with CI- (GMP: glutamate+malate), CI+II- (GMSP and GMSE: glutamate+malate+succinate), and CII-substrate (S(Rot)E: succinate+rotenone); N: number of horses (2 or 3 runs per horse); n = number of runs for this horse. See text for other abbreviations.


References

  1. McCue ME, Valberg SJ, Miller MB, Wade C, DiMauro S, Akman HO, Mickelson, JR (2008) Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis. Genomics 91: 458-466.
  2. Votion DM, Van Galen G, Sweetman L, Boemer F, de Tullio P, Dopagne C, Lefรจre L, Mouihys-Mickalad A, Patarin F, Rouxhet S, Van Loon G, Serteyn D, Sponseller BT, Valberg SJ (2013) The toxic metabolite causing equine atypical myopathy in europe has been identified. Submitted.
  3. Votion DM, Gnaiger E, Lemieux H, Mouithys-Mickalad A, Serteyn D (2012) Physical fitness and mitochondrial respiratory capacity in horse skeletal muscle. PLoS One 7: e34890.